As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 4, 2000, Pages 732-738

  Jen, Albert ^a   Baroody, Fuad ^a   DeTineo, Marcy ^a   Haney, Lauran ^a   Blair, Christopher ^a   Naclerio, Robert M ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Allergic rhinitis; Eosinophil cationic protein; Eosinophils; Fluticasone propionate nasal spray

Indexed keywords

FLUTICASONE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; SYMPTOMATOLOGY;

EID: 0034048841     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.105225     Document Type: Article

References (13)

1. 1. Evans R. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis. In: Middleton E Jr, Reed C, Ellis E, et al, editors. Allergy: principles and practice. 4th ed. St Louis: Mosby-Year Book; 1993. p 1109-36.
2. 2. Naclerio RM, Solomon W. Rhinitis and inhalant allergens. JAMA 1997;278:1842-8.
3. 3. LaForce CF, Dockhorn RJ, Findlay SR, Meltzer EO, Nathan RA, Stricker W, et al. Fluticasone propionate: an effective alternative treatment for seasonal allergie rhinitis in adults and adolescents. J Fam Pract 1994;38:145-52.
4. 4. Anderson M, Anderson P, Pipkorn U. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity: relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 1988;82:1019-26.
5. 5. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77-83.
6. 6. Lim MC, Taylor RM, Naclerio RM. The histology of allergic rhinitis and its comparison to nasal lavage. Am J Respir Crit Care Med 1995;151:136-44.
7. 7. Mygind N, Naclerio RM. Intranasal corticosteroids. In: Naclerio RM, Durham SR, Mygind N, editors. Rhinitis mechanisms and management. New York: Marcel Dekker; 1998. p 221-56.
8. 8. Juniper EF, Guyatt GH, O'Byrne PM, Viveiros M. Aqueous beclomethasone dipropionate nasal spray: regular vs "as required" use in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1990;86:380-6.
9. 9. Juniper EF, Guyatt GH, Archer B, Ferrie PJ. Aqueous beclomethasone diproprionate in the treatment of ragweed pollen-induced rhinitis: further exploration of "as needed" use. J Allergy Clin Immunol 1993;92:66-72.
10. 10. Noon JP, Evans CE, Haynes WG, Webb DJ, Walker BR. A comparison of techniques to assess skin blanching following the topical application of glucocorticoids. Br J Dermatol 1996;134:837-42.
11. 11. Bende M, Lindquist N, Pipkorn U. Effect of a topical glucocorticoid, budesonide, on nasal mucosal blood flow as measured with 133Xe washout technique. Allergy 1983;38:461-4.
12. 12. Majchel AM, Baroody F, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol 1993;92:767-70.
13. 13. Bavel J, Findlay S, Hampel FC, Martin BG, Ratner P, Field E. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994;154:2699-704.